Keywords
Balance
Walking
Health care
Psychosocial impact
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To verify the behavior of depressive symptoms, fatigue, postural balance and walking in women with Multiple Sclerosis (MS), before isolation and after the end of social isolation, a measure introduced by the Covid pandemic-19. Methods: The sample of this longitudinal, prospective study included 15 women with MS. Using the Patient Determined Disease Scale (PDDS), we categorized two groups, without walking disability (GSI) and with disability (GCI). We assessed, in two moments, the presence of depressive symptoms using the Beck inventory (BECK-II), severity of fatigue (FSS) and its impact (MFIS), postural balance (posturography) and walking (25-foot walk test). To compare the variables collected at different moments, we used a paired t test. Results: We found significant improvements and a moderate effect size (p<0.05 and ES>0.50) in GCI depressive symptoms and fatigue after the isolation. We did not find significant differences in the other comparisons. Conclusion: As the main finding, we showed that for GCI, returning to social life was enough for a significant improvement in depressive symptoms and fatigue. We therefore highlight the importance of health care aimed at the psychosocial domain in the population of women with MS and disability to walk.
References
ALSCHULER KN, et al. Distress and risk perception in people living with multiple sclerosis during the early phase of the COVID-19 pandemic. Mult Scler Relat Disord., 2021; 47: 102618.
ALTUNAN B, et al. Coping with stress during the first wave of the COVID-19 pandemic by Turkish people with Multiple Sclerosis: The relationship between perceived stress and quality of life. Mult Scler Relat Disord., 2021; 53: 103039.
ANDREU-CARAVACA L, et al. The impact of COVID-19 home confinement on neuromuscular performance, functional capacity, and psychological state in Spanish people with Multiple Sclerosis. Mult Scler Relat Disord., 2021; 53: 103047.
BONAVITA S, et al. Perceived stress and social support in a large population of people with multiple sclerosis recruited online through the COVID-19 pandemic. Eur J Neurol., 2021; 28(10): 3396-3402.
CAPUANO R, et al. Psychological consequences of COVID-19 pandemic in Italian MS patients: signs of resilience? J Neurol., 2021; 268(3): 743-750.
CAPUTO EL e REICHERT FF. Studies of Physical Activity and COVID-19 During the Pandemic: A Scoping Review. J Phys Act Health, 2020; 17(12): 1275-1284.
CHALAH MA, et al. Fatigue in Multiple Sclerosis: Neural Correlates and the Role of Non-Invasive Brain Stimulation. Front Cell Neurosci., 2015; 9: 460.
CHIARAVALLOTI ND, et al. The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis. J Neurol., 2021; 268(5): 1598-1607.
COHEN J. Statistical power analysis for the behavioral sciences Lawrence Earlbaum Associates. 20th–. Published online 1988.
COMPSTON A e COLES A. Multiple sclerosis. The Lancet, 2008; 372(9648): 1502-1517.
COSTABILE T, et al. COVID-19 pandemic and mental distress in multiple sclerosis: Implications for clinical management. Eur J Neurol., 2021; 28(10): 3375-3383.
DONZÉ C e MASSOT C. Rehabilitation in multiple sclerosis in 2021. Presse Médicale, 2021; 50(2): 104066.
DOSHI A e CHATAWAY J. Multiple sclerosis, a treatable disease. Clin Med., 2017; 17(6): 530-536.
FEINSTEIN A, et al. The late onset of emotional distress in people with progressive multiple sclerosis during the Covid-19 pandemic: longitudinal findings from the CogEx study. J Neurol., 2022; 269(12): 6202-6210.
FIORILLO A, et al. Effects of the lockdown on the mental health of the general population during the COVID-19 pandemic in Italy: Results from the COMET collaborative network. Eur Psychiatry J Assoc Eur Psychiatr., 2020; 63(1): e87.
FISCHER JS, et al. The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force. Mult Scler Houndmills Basingstoke Engl., 1999; 5(4): 244-250.
FISK JD, et al. The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci J Can Sci Neurol., 1994; 21(1): 9-14.
GOMES-OLIVEIRA MH, et al. Validation of the Brazilian Portuguese version of the Beck Depression Inventory-II in a community sample. Rev Bras Psiquiatr Sao Paulo Braz, 2012; 34(4): 389-394.
HOHOL MJ, et al. Disease steps in multiple sclerosis: a simple approach to evaluate disease progression. Neurology, 1995; 45(2): 251-255.
KOOPMANN A, et al. The Effects of the Lockdown during the COVID-19 Pandemic on Alcohol and Tobacco Consumption Behavior in Germany. Eur Addict Res., 2021; 27(4): 242-256.
KURTZKE JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology, 1983; 33(11): 1444-1452.
LEARMONTH YC, et al. Psychometric properties of the Fatigue Severity Scale and the Modified Fatigue Impact Scale. J Neurol Sci., 2013; 331(1-2): 102-107.
LEARMONTH YC, et al. Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis. BMC Neurol., 2013; 13: 37.
LEE G e PARK AE. Development of a more robust tool for postural stability analysis of laparoscopic surgeons. Surg Endosc., 2008; 22(4): 1087-1092.
MORRIS-BANKOLE H e HO AK. The COVID-19 Pandemic Experience in Multiple Sclerosis: The Good, the Bad and the Neutral. Neurol Ther., 2021; 10(1): 279-291.
MOTL RW, et al. Symptoms, self-efficacy, and physical activity among individuals with multiple sclerosis. Res Nurs Health, 2006; 29(6): 597-606.
MOTOLESE F, et al. The Psychological Impact of COVID-19 Pandemic on People With Multiple Sclerosis. Front Neurol. 2020;11:580507.
PATEJDL R, et al. Multiple sclerosis and fatigue: A review on the contribution of inflammation and immune-mediated neurodegeneration. Autoimmun Rev. 2016;15(3):210-220.
POLMAN CH, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292-302.
RAYMAKERS JA, et al. The assessment of body sway and the choice of the stability parameter(s). Gait Posture. 2005;21(1):48-58.
SACCO R, et al. Psychometric properties and validity of Beck Depression Inventory II in multiple sclerosis. Eur J Neurol. 2016;23(4):744-750.
SCOPPA F, et al. Clinical stabilometry standardization: Basic definitions – Acquisition interval – Sampling frequency. Gait Posture. 2013;37(2):290-292.
SOLARO C, et al. Depression in Multiple Sclerosis: Epidemiology, Aetiology, Diagnosis and Treatment. CNS Drugs. 2018;32(2):117-133.
STOJANOV A, et al. Psychological status of patients with relapsing-remitting multiple sclerosis during coronavirus disease-2019 outbreak. Mult Scler Relat Disord. 2020;45:102407.
THOMPSON AJ, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162-173.
VAN EMMERIK REA, et al. Postural control in women with multiple sclerosis: effects of task, vision and symptomatic fatigue. Gait Posture. 2010;32(4):608-614.
VERCELLINO M, et al. Impact of COVID-19 lockdown on progressive multiple sclerosis patients. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol. 2022;43(5):2943-2946.
WEILAND TJ, et al. Clinically Significant Fatigue: Prevalence and Associated Factors in an International Sample of Adults with Multiple Sclerosis Recruited via the Internet. PLOS ONE. 2015;10(2):e0115541.
WILSKI M, et al. Mental Health Status of People with Multiple Sclerosis during the COVID-19 Pandemic. J Clin Med. 2022;11(3):576.
ZANGHÌ A, et al. Mental health status of relapsing-remitting multiple sclerosis Italian patients returning to work soon after the easing of lockdown during COVID-19 pandemic: A monocentric experience. Mult Scler Relat Disord. 2020;46:102561.